David R Boulware Selected Research

Cryptococcal Meningitis

9/2022	Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis.
2/2022	Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.
1/2022	Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
11/2021	Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.
9/2021	High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
9/2021	Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population.
7/2021	Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.
3/2021	HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
1/2021	Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis.
1/2021	Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Boulware Research Topics

Disease

79	Cryptococcal Meningitis 09/2022 - 06/2008
27	Meningitis 09/2022 - 01/2013
21	Acquired Immunodeficiency Syndrome (AIDS) 02/2022 - 09/2010
18	Infections 12/2020 - 11/2005
17	Meningeal Tuberculosis (Tuberculous Meningitis) 09/2022 - 12/2013
17	COVID-19 07/2022 - 01/2020
16	Cryptococcosis 09/2021 - 08/2010
16	Immune Reconstitution Inflammatory Syndrome 05/2019 - 01/2008
8	Inflammation (Inflammations) 01/2021 - 09/2010
5	HIV Infections (HIV Infection) 01/2021 - 11/2010
5	Coinfection 12/2020 - 05/2013
5	Opportunistic Infections (Opportunistic Infection) 08/2020 - 07/2008
5	Tuberculosis (Tuberculoses) 08/2020 - 01/2019
4	Malaria 10/2020 - 06/2004
3	Body Weight (Weight, Body) 01/2022 - 06/2014
3	Pneumonia (Pneumonitis) 01/2020 - 10/2007
3	Asymptomatic Infections 02/2016 - 01/2013
2	Mycoses (Diseases, Fungus) 06/2022 - 03/2015
2	Sepsis (Septicemia) 01/2022 - 12/2021
2	Disease Progression 01/2022 - 10/2015
2	Diarrhea 11/2020 - 01/2004
2	Hypokalemia 12/2019 - 09/2014
2	Blastomycosis 03/2019 - 04/2016
2	Bites and Stings (Sting) 03/2016 - 01/2005
2	Bacteremia 04/2014 - 05/2011
2	Pneumococcal Pneumonia 01/2013 - 10/2007
1	Viremia 09/2022
1	Clinical Deterioration 12/2021
1	Viral Meningitis 11/2021
1	Seizures (Absence Seizure) 11/2021
1	Anemia 07/2021
1	AIDS-Related Opportunistic Infections 07/2021
1	Acute-Phase Reaction 01/2021
1	Cognitive Dysfunction 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Serotonin Syndrome (Syndrome, Serotonin) 11/2020
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	Vomiting 11/2020
1	Nausea 11/2020

Drug/Important Bio-Agent (IBA)

42	AntigensIBA 02/2022 - 10/2007
20	Fluconazole (Zonal)FDA LinkGeneric 02/2022 - 08/2010
17	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2021 - 06/2008
15	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2008
12	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2022 - 01/2020
9	CytokinesIBA 12/2021 - 09/2010
8	Sertraline (Zoloft)FDA LinkGeneric 11/2020 - 07/2016
7	deoxycholate drug combination amphotericin BIBA 01/2022 - 09/2014
6	Flucytosine (Ancobon)FDA Link 01/2022 - 06/2015
5	liposomal amphotericin B FDA Link 02/2022 - 11/2018
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2010
4	Fluvoxamine (Luvox)FDA LinkGeneric 01/2022 - 02/2021
4	lipoarabinomannan (LAM)IBA 11/2021 - 01/2016
4	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2018
4	chinese inkIBA 01/2019 - 01/2014
3	Pharmaceutical PreparationsIBA 08/2020 - 04/2014
3	Capsules (Microcapsules)IBA 05/2019 - 01/2014
3	InterferonsIBA 01/2017 - 06/2011
3	Interleukin-8 (Interleukin 8)IBA 01/2014 - 09/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 09/2010
2	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 11/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 11/2021
2	C-Reactive ProteinIBA 12/2020 - 06/2011
2	Azithromycin (Zithromax)FDA LinkGeneric 11/2020 - 09/2020
2	Antimalarials (Antimalarial Agents)IBA 10/2020 - 09/2007
2	Chloroquine (Aralen)FDA LinkGeneric 04/2020 - 11/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2005
2	ChemokinesIBA 01/2020 - 02/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2019 - 04/2016
2	glucuronoxylomannanIBA 05/2019 - 01/2016
2	AntibodiesIBA 03/2019 - 08/2016
2	EnzymesIBA 03/2019 - 03/2015
2	Tenofovir (Viread)FDA Link 01/2019 - 01/2016
2	Nucleic AcidsIBA 01/2017 - 01/2014
2	Insect RepellentsIBA 03/2016 - 01/2005
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 05/2013
2	RNA (Ribonucleic Acid)IBA 02/2014 - 06/2011
2	Interferon-gamma (Interferon, gamma)IBA 12/2011 - 09/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2011 - 09/2010
1	Antifungal AgentsIBA 06/2022
1	Guanosine Diphosphate (GDP)IBA 02/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	AcidsIBA 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021
1	Sigma-1 ReceptorIBA 12/2021
1	Biological ProductsIBA 07/2021
1	InflammasomesIBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2020
1	polyglucosanIBA 01/2020
1	polysaccharide-KIBA 01/2020

Therapy/Procedure

53	Therapeutics 02/2022 - 11/2005
32	Art Therapy 09/2022 - 01/2008
3	Retention in Care 01/2019 - 05/2013
2	Chemoprevention 10/2020 - 06/2004
2	Complementary Therapies (Alternative Medicine) 01/2017 - 06/2015
2	Highly Active Antiretroviral Therapy (HAART) 05/2013 - 06/2008
1	Animal Assisted Therapy 01/2020